MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $71.1B— | $57.0B-19.9% | $54.3B-4.8% | $70.7B+30.2% | $61.0B-13.7% |
| EPS (dil.) | $19.51— | $-4.49-123.0% | $6.74n/m | $7.50+11.3% | $10.22+36.3% |
| Free Cash Flow | $10.5B— | $5.2B-51.1% | $6.5B+26.2% | $8.5B+30.6% | $6.3B-26.2% |
| Gross Margin | 39.7% | 20.9%-18.9pp | 32.4%+11.5pp | 24.8%-7.6pp | 31.1%+6.3pp |
| Operating Margin | 15.2% | -3.3%-18.5pp | 5.7%+9.0pp | 4.5%-1.1pp | 7.6%+3.1pp |
| Net Margin | 12.5% | -2.9%-15.4pp | 4.6%+7.5pp | 3.9%-0.7pp | 5.9%+2.0pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $111 avg across 5 analysts.
Buy-rated share 5% → 0% over ~3 months (-5pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $3.52 | $4.08 | +15.9% |
| May 2026 | $3.09 | $3.61 | +16.8% |
| Feb 2026 | $3.37 | $3.30 | -2.1% |
| Oct 2025 | $3.72 | $4.26 | +14.5% |
| Jul 2025 | $3.22 | $3.58 | +11.2% |
| Apr 2025 | $3.18 | $3.29 | +3.5% |
| Feb 2025 | $3.36 | $2.96 | -11.9% |
| Oct 2024 | $3.47 | $3.48 | +0.3% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 3.0%/yr (revenue basis).
Base free cash flow $7.1B (avg FY2023–FY2025; latest year $6.3B) · equity value $42.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$1.4M over 180 days (0 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 57 for PRU suggests a neutral outlook, with the stock's strengths and weaknesses balancing out. The stock scores high on value, with a P/E of 11.1 and P/B of 1.3, and exhibits strong momentum, with a 12-month return of 17.1% and a bullish 50-day versus 200-day moving average. However, growth and profitability scores are lower, driven by negative revenue and free cash flow growth, as well as moderate return on equity of 12.0%. The long-term and short-term scores are relatively close, with only a 5-point difference.